Epilepszia: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• NMDA 0
• mTOR 3
• SCN1A 6
• SCN2A 2
• HMGB1 0
• PPAR 0
• BDNF 1
• NLRP3 0
• TLR4 0
• NRF2 0
• PTEN 0
• AKT 0
• PI3K 0
• IDH 0
• GLP-1 0
• IL-1 1
• JAK 0
• GPX4 0
• AMPK 0
• CTNNB1 1
• MAPK 0
• APOE 0
• COX-2 0
• SGLT2 0
• SIRT1 0
• STING 0
• TNF 0
• ERK 1
• HIF-1 0
• STAT3 0
• TP53 0
• TREM2 0
• CGRP 0
• HDAC 0
• MAPT 0
• YAP 0
• APP 0
• CXCR4 0
• HSP90 0
• IL-6 0
• JNK 0
• MDM2 0
• NOTCH1 0
• NOTCH3 0
• PD-1 0
• PINK1 0
• AQP4 0
• AR 0
• B7-H3 0
• BACE1 0
• BCL-2 0
• BRAF 0
• BRD4 0
• CD47 0
• DMD 0
• DPP-4 0
• FGFR 0
• FTO 0
• G6PD 0
• GBA1 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIMH · F30

  Neural Correlates of Memory-Based Generalization in Humans

  University of California at Davis· Davis, Egyesült Államok· 43 749 USD awarded in fiscal year 2026· until 2030. szept.

• ALLCDC NCCDPHP · U01

  Epilepsy Incidence Among Children in the United States

  National Opinion Research Center· Chicago, Egyesült Államok· 443 851 USD awarded in fiscal year 2025· until 2030. szept.

• ALLCDC NCCDPHP · U01

  Advancing Understanding of Pediatric Epilepsy Incidence and Risk Factors: A Multilevel Population Health Approach

  Massachusetts General Hospital· Boston, Egyesült Államok· 418 550 USD awarded in fiscal year 2025· until 2030. szept.

• NIH NINDS · F31

  Slow-Wave Sleep Enhancement to Treat Epilepsy

  University of California at Davis· Davis, Egyesült Államok· 43 749 USD awarded in fiscal year 2026· until 2029. szept.

• ALLCDC NCCDPHP · U01

  Incidence and Risk Factors of Childhood Epilepsy in the United States

  Case Western Reserve University· Cleveland, Egyesült Államok· 499 995 USD awarded in fiscal year 2025· until 2030. szept.

• European Commission (Horizon Europe) · HORIZON-ERC

  From single neuron to brain: multi-level strategy and digital twins for personalized prediction of treatment (Neuron2Brain)

  Universita Degli Studi di Genova· Genova, Olaszország· EU contribution 1 500 000 EUR· until 2032. febr.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unravelling the Role of Cerebral Amyloid-beta Angiopathy in Epilepsy: Inflammatory Pathways and Interneuron Dysfunction (EPICAA)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Németország· EU contribution 217 965 EUR· until 2029. febr.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  The role of subcortical structures in perceptual consciousness: a causal investigation (StimConscious)

  Katholieke Universiteit Leuven· Leuven, Belgium· EU contribution 424 129 EUR· until 2030. jan.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Standardized patient‑friendly computational language mapping to guide epilepsy surgery (SPEEDY-Clinic)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 150 000 EUR· until 2028. jún.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  High-throughput screen for disfunctions in GABA-switch in human neuronal models of SNAREopathies

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2028. okt.

  The disease is named only in the funder's project summary, not in the title.

10 of 1283 running projects, newest first. Listed amounts together: 626,6 M USD + 184,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

  NCT01238250· Simons Searchlight· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 8
• Organoids 13
• Mendelian Randomization Analysis 36
• CRISPR-Cas Systems 9
• Gene Expression Profiling 28
• Sequence Analysis, RNA 4
• Whole Genome Sequencing 14
• Exome Sequencing 114
• Proteomics 23
• Metabolomics 23
• Mass Spectrometry 7
• Flow Cytometry 3
• Immunohistochemistry 21
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 70
• Magnetic Resonance Imaging 573
• Machine Learning 112
• Deep Learning 78
• Cohort Studies 313
• Genome-Wide Association Study 37

• Optimized nuclei isolation and snRNA-seq reveal oligodendrocyte pathway dysregulation in MOGHE brain tissue from pediatric patients.

  Sci Rep, 2026. máj.

• Single-nucleus RNA sequencing reveals ferroptosis as a potential contributor to the pathogenesis of focal cortical dysplasia.

  Clin Transl Med, 2026. máj.

• Identification of epileptic hippocampal sclerosis related genes through bulk and single-nucleus RNA sequencing datasets.

  Cell Mol Life Sci, 2025. dec.

• Mechanistic study of the cytotoxicity of cannabidiol and its metabolites in HepG2 cells.

  Arch Toxicol, 2025. nov.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.